Library Item - Page 12 of 792 Posts on Medivizor
Navigation Menu

Library Item Posts on Medivizor

Evaluating the role of radiotherapy in HER2+ early-stage breast cancer after breast-conserving surgery

Evaluating the role of radiotherapy in HER2+ early-stage breast cancer after breast-conserving surgery

Posted by on Mar 5, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the effectiveness of radiotherapy (RT) in patients with HER2+ early-stage breast cancer (BC) after breast-conserving surgery (BCS). The study found that RT improved the survival rates of these patients, especially for those high-risk. Some background BC is categorized based on the absence or...

Read More

Comparing the effectiveness of vaginal laser therapy and hyaluronic acid suppositories in women with urogenital atrophy after breast cancer treatment

Comparing the effectiveness of vaginal laser therapy and hyaluronic acid suppositories in women with urogenital atrophy after breast cancer treatment

Posted by on Mar 5, 2023 in Breast cancer | 0 comments

In a nutshell The study evaluated the effectiveness of vaginal laser therapy (VL) and hyaluronic acid suppositories (HAS) in women with urogenital atrophy after having breast cancer (BC) treatment. The data found that both VA therapy and HAS were equally effective in treating urogenital atrophy in these patients. Some background Many women...

Read More

Comparing the effects of different physical and rehabilitation therapies in women with overactive bladder

Comparing the effects of different physical and rehabilitation therapies in women with overactive bladder

Posted by on Mar 5, 2023 in Overactive bladder | 0 comments

In a nutshell The study compared the effects of different physical and rehabilitation therapies in women with overactive bladder (OAB). The study found that percutaneous tibial nerve stimulation (PTNS) alone, a combination of bladder training (BT) with electrical stimulation (ES), and a combination of BT and ES with biofeedback (BF) were effective for...

Read More

Evaluating the effectiveness of a luteinizing hormone-based modified GnRH antagonist protocol in patients with normal ovarian response undergoing in vitro fertilization treatment.

Evaluating the effectiveness of a luteinizing hormone-based modified GnRH antagonist protocol in patients with normal ovarian response undergoing in vitro fertilization treatment.

Posted by on Feb 28, 2023 in Infertility | 0 comments

In a nutshell This study evaluated the clinical and cost-effectiveness of a luteinizing hormone (LH)-based modified gonadotrophin-releasing hormone (GnRH) antagonist protocol in patients with normal ovarian response undergoing in vitro fertilization (IVF) treatment. The data showed that the LH-based modified GnRH antagonist protocol was more...

Read More

Evaluating the risk of cardiovascular disease mortality among long-term survivors of classical Hodgkin lymphoma.

Evaluating the risk of cardiovascular disease mortality among long-term survivors of classical Hodgkin lymphoma.

Posted by on Feb 28, 2023 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the risk of cardiovascular disease mortality among long-term survivors of classical Hodgkin lymphoma (cHL). The data showed that patients with early-stage HL are at a higher risk of mortality from cardiovascular disease than from cancer. Some background cHL is a cancer that starts in white blood cells called...

Read More

Evaluating the effectiveness and safety of zanubrutinib versus ibrutinib in patients with Waldenström Macroglobulinemia.

Evaluating the effectiveness and safety of zanubrutinib versus ibrutinib in patients with Waldenström Macroglobulinemia.

Posted by on Feb 28, 2023 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of zanubrutinib (Brukinsa) versus ibrutinib (Imbruvica) in patients with Waldenström Macroglobulinemia (WM). The data showed that zanubrutinib had higher long-term response rates and lower side effects than ibrutinib in these patients. Some background WM is a type of cancer in which...

Read More

Evaluating the effectiveness of lenalidomide-containing triplet regimens in patients with first relapsed multiple myeloma.

Evaluating the effectiveness of lenalidomide-containing triplet regimens in patients with first relapsed multiple myeloma.

Posted by on Feb 28, 2023 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the effectiveness of lenalidomide (Revlimid)-containing regimens in patients with first relapsed multiple myeloma (MM). The data showed that daratumumab (Darzalex) combined with lenalidomide and dexamethasone (Rd) regimen significantly increased the survival without cancer worsening with fewer serious side effects...

Read More

Evaluating the effectiveness of acupuncture for the treatment of anxiety in patients with Parkinson’s disease.

Evaluating the effectiveness of acupuncture for the treatment of anxiety in patients with Parkinson’s disease.

Posted by on Feb 28, 2023 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness of acupuncture for the treatment of anxiety in patients with Parkinson’s disease (PD). The data showed that acupuncture was an effective treatment for anxiety and improved the well-being of these patients. Some background Parkinson's disease (PD) is a disorder in which part of the brain is...

Read More

Evaluating the effectiveness and safety of gilteritinib plus azacitidine versus azacitidine alone for patients with newly diagnosed FLT3-mutated acute myeloid leukemia.

Evaluating the effectiveness and safety of gilteritinib plus azacitidine versus azacitidine alone for patients with newly diagnosed FLT3-mutated acute myeloid leukemia.

Posted by on Feb 28, 2023 in Leukemia | 0 comments

In a nutshell This study investigated the effectiveness and safety of gilteritinib (Xospata) plus azacitidine (Vidaza) versus azacitidine alone for patients with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemia (AML) who are unfit for intensive chemotherapy. The data showed that gilteritinib plus azacitidine...

Read More

Evaluating the effectiveness and safety of robotic versus laparoscopic resections for patients with low rectal cancer.

Evaluating the effectiveness and safety of robotic versus laparoscopic resections for patients with low rectal cancer.

Posted by on Feb 27, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of robotic versus laparoscopic abdominoperineal resections (APRs) for the treatment of patients with low rectal cancer (RC). The data showed that robotic APRs significantly reduced surgical trauma and promoted recovery after surgery compared with laparoscopic APRs in these patients. Some...

Read More

Comparing the effectiveness and safety between immune checkpoint inhibitors and docetaxel in patients with non-small cell lung cancer.

Comparing the effectiveness and safety between immune checkpoint inhibitors and docetaxel in patients with non-small cell lung cancer.

Posted by on Feb 27, 2023 in Lung cancer | 0 comments

In a nutshell This study compared the effectiveness and safety between immune checkpoint inhibitors (ICIs) and docetaxel (Taxotere) therapy alone in patients with non-small cell lung cancer (NSCLC). The data showed ICIs significantly improved the survival outcomes with fewer serious side effects compared to docetaxel alone for the treatment of patients...

Read More

Comparing the effectiveness and safety of intralesional verapamil and collagenase Clostridium histolyticum injections in men with Peyronie’s disease.

Comparing the effectiveness and safety of intralesional verapamil and collagenase Clostridium histolyticum injections in men with Peyronie’s disease.

Posted by on Feb 27, 2023 in Erectile dysfunction | 0 comments

In a nutshell This study compared the effectiveness and safety of intralesional verapamil (Calan; ILV) and collagenase Clostridium histolyticum (Xiaflex; CCH) injections in men with Peyronie’s disease (PD). The data showed that CCH therapy was more effective than ILV, with a higher high level of patient satisfaction rate in the short term...

Read More